Protein Kinase C-Mediated Phosphorylation of BCL11B at Serine 2 Negatively Regulates Its Interaction with NuRD Complexes during CD4⁺ T-Cell Activation

REFERENCES

• Avram D, Fields A, Pretty On Top K, Nevrivy DJ, Ishmael JE, Leid M. 2000. Isolation of a novel family of C(2)H(2) zinc finger proteins implicated in transcriptional repression mediated by chicken ovalbumin upstream promoter transcription factor (COUP-TF) orphan nuclear receptors. J Biol Chem 275:10315–10322. http://dx.doi.org/10.1074/jbc.275.14.10315.
   PubMed Web of Science ®Google Scholar
• Avram D, Fields A, Senawong T, Topark-Ngarm A, Leid M. 2002. COUP-TF (chicken ovalbumin upstream promoter transcription factor)-interacting protein 1 (CTIP1) is a sequence-specific DNA binding protein. Biochem J 368:555–563. http://dx.doi.org/10.1042/bj20020496.
   PubMed Web of Science ®Google Scholar
• Wakabayashi Y, Inoue J, Takahashi Y, Matsuki A, Kosugi-Okano H, Shinbo T, Mishima Y, Niwa O, Kominami R. 2003. Homozygous deletions and point mutations of the Rit1/Bcl11b gene in gamma-ray induced mouse thymic lymphomas. Biochem Biophys Res Commun 301:598–603. http://dx.doi.org/10.1016/S0006-291X(02)03069-3.
   PubMedGoogle Scholar
• Avram D, Califano D. 2014. The multifaceted roles of Bcl11b in thymic and peripheral T cells: impact on immune diseases. J Immunol 193:2059–2065. http://dx.doi.org/10.4049/jimmunol.1400930.
   PubMedGoogle Scholar
• Wakabayashi Y, Watanabe H, Inoue J, Takeda N, Sakata J, Mishima Y, Hitomi J, Yamamoto T, Utsuyama M, Niwa O, Aizawa S, Kominami R. 2003. Bcl11b is required for differentiation and survival of alphabeta T lymphocytes. Nat Immunol 4:533–539. http://dx.doi.org/10.1038/ni927.
   PubMed Web of Science ®Google Scholar
• Albu DI, Feng D, Bhattacharya D, Jenkins NA, Copeland NG, Liu P, Avram D. 2007. BCL11B is required for positive selection and survival of double-positive thymocytes. J Exp Med 204:3003–3015. http://dx.doi.org/10.1084/jem.20070863.
   PubMedGoogle Scholar
• Li L, Leid M, Rothenberg EV. 2010. An early T cell lineage commitment checkpoint dependent on the transcription factor Bcl11b. Science 329:89–93. http://dx.doi.org/10.1126/science.1188989.
   PubMed Web of Science ®Google Scholar
• Li P, Burke S, Wang J, Chen X, Ortiz M, Lee SC, Lu D, Campos L, Goulding D, Ng BL, Dougan G, Huntly B, Gottgens B, Jenkins NA, Copeland NG, Colucci F, Liu P. 2010. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329:85–89. http://dx.doi.org/10.1126/science.1188063.
   PubMed Web of Science ®Google Scholar
• Kastner P, Chan S, Vogel WK, Zhang LJ, Topark-Ngarm A, Golonzhka O, Jost B, Le Gras S, Gross MK, Leid M. 2010. Bcl11b represses a mature T-cell gene expression program in immature CD4(+)CD8(+) thymocytes. Eur J Immunol 40:2143–2154. http://dx.doi.org/10.1002/eji.200940258.
   PubMedGoogle Scholar
• Gutierrez A, Kentsis A, Sanda T, Holmfeldt L, Chen SC, Zhang J, Protopopov A, Chin L, Dahlberg SE, Neuberg DS, Silverman LB, Winter SS, Hunger SP, Sallan SE, Zha S, Alt FW, Downing JR, Mullighan CG, Look AT. 2011. The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemia. Blood 118:4169–4173. http://dx.doi.org/10.1182/blood-2010-11-318873.
   PubMed Web of Science ®Google Scholar
• Kominami R. 2012. Role of the transcription factor Bcl11b in development and lymphomagenesis. Proc Jpn Acad Ser B Phys Biol Sci 88:72–87. http://dx.doi.org/10.2183/pjab.88.72.
   PubMedGoogle Scholar
• Di Santo JP. 2010. Immunology. A guardian of T cell fate. Science 329:44–45. http://dx.doi.org/10.1126/science.1191664.
   PubMedGoogle Scholar
• Liu P, Keller JR, Ortiz M, Tessarollo L, Rachel RA, Nakamura T, Jenkins NA, Copeland NG. 2003. Bcl11a is essential for normal lymphoid development. Nat Immunol 4:525–532. http://dx.doi.org/10.1038/ni925.
   PubMed Web of Science ®Google Scholar
• Sankaran VG, Xu J, Ragoczy T, Ippolito GC, Walkley CR, Maika SD, Fujiwara Y, Ito M, Groudine M, Bender MA, Tucker PW, Orkin SH. 2009. Developmental and species-divergent globin switching are driven by BCL11A. Nature 460:1093–1097. http://dx.doi.org/10.1038/nature08243.
   PubMed Web of Science ®Google Scholar
• Bauer DE, Kamran SC, Orkin SH. 2012. Reawakening fetal hemoglobin: prospects for new therapies for the beta-globin disorders. Blood 120:2945–2953. http://dx.doi.org/10.1182/blood-2012-06-292078.
   PubMed Web of Science ®Google Scholar
• Le Douce V, Cherrier T, Riclet R, Rohr O, Schwartz C. 2014. The many lives of CTIP2: from AIDS to cancer and cardiac hypertrophy. J Cell Physiol 229:533–537. http://dx.doi.org/10.1002/jcp.24490.
   PubMedGoogle Scholar
• Marban C, Suzanne S, Dequiedt F, de Walque S, Redel L, Van Lint C, Aunis D, Rohr O. 2007. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J 26:412–423. http://dx.doi.org/10.1038/sj.emboj.7601516.
   PubMed Web of Science ®Google Scholar
• Cismasiu VB, Adamo K, Gecewicz J, Duque J, Lin Q, Avram D. 2005. BCL11B functionally associates with the NuRD complex in T lymphocytes to repress targeted promoter. Oncogene 24:6753–6764. http://dx.doi.org/10.1038/sj.onc.1208904.
   PubMed Web of Science ®Google Scholar
• Cismasiu VB, Ghanta S, Duque J, Albu DI, Chen HM, Kasturi R, Avram D. 2006. BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes. Blood 108:2695–2702. http://dx.doi.org/10.1182/blood-2006-05-021790.
   PubMed Web of Science ®Google Scholar
• Cismasiu VB, Duque J, Paskaleva E, Califano D, Ghanta S, Young HA, Avram D. 2009. BCL11B enhances TCR/CD28-triggered NF-kappaB activation through up-regulation of Cot kinase gene expression in T-lymphocytes. Biochem J 417:457–466. http://dx.doi.org/10.1042/BJ20080925.
   PubMedGoogle Scholar
• Zhang LJ, Vogel WK, Liu X, Topark-Ngarm A, Arbogast BL, Maier CS, Filtz TM, Leid M. 2012. Coordinated regulation of transcription factor Bcl11b activity in thymocytes by the mitogen-activated protein kinase (MAPK) pathways and protein sumoylation. J Biol Chem 287:26971–26988. http://dx.doi.org/10.1074/jbc.M112.344176.
   PubMedGoogle Scholar
• Filtz TM, Vogel WK, Leid M. 2014. Regulation of transcription factor activity by interconnected post-translational modifications. Trends Pharmacol Sci 35:76–85. http://dx.doi.org/10.1016/j.tips.2013.11.005.
   PubMed Web of Science ®Google Scholar
• Azzaoui I, Yahia SA, Chang Y, Vorng H, Morales O, Fan Y, Delhem N, Ple C, Tonnel AB, Wallaert B, Tsicopoulos A. 2011. CCL18 differentiates dendritic cells in tolerogenic cells able to prime regulatory T cells in healthy subjects. Blood 118:3549–3558. http://dx.doi.org/10.1182/blood-2011-02-338780.
   PubMed Web of Science ®Google Scholar
• Cherrier T, Le Douce V, Eilebrecht S, Riclet R, Marban C, Dequiedt F, Goumon Y, Paillart JC, Mericskay M, Parlakian A, Bausero P, Abbas W, Herbein G, Kurdistani SK, Grana X, Van Driessche B, Schwartz C, Candolfi E, Benecke AG, Van Lint C, Rohr O. 2013. CTIP2 is a negative regulator of P-TEFb. Proc Natl Acad Sci U S A 110:12655–12660. http://dx.doi.org/10.1073/pnas.1220136110.
   PubMedGoogle Scholar
• Stankovic-Valentin N, Deltour S, Seeler J, Pinte S, Vergoten G, Guerardel C, Dejean A, Leprince D. 2007. An acetylation/deacetylation-SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol Cell Biol 27:2661–2675. http://dx.doi.org/10.1128/MCB.01098-06.
   PubMedGoogle Scholar
• Lauberth SM, Rauchman M. 2006. A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex. J Biol Chem 281:23922–23931. http://dx.doi.org/10.1074/jbc.M513461200.
   PubMed Web of Science ®Google Scholar
• Lauberth SM, Bilyeu AC, Firulli BA, Kroll KL, Rauchman M. 2007. A phosphomimetic mutation in the Sall1 repression motif disrupts recruitment of the nucleosome remodeling and deacetylase complex and repression of Gbx2. J Biol Chem 282:34858–34868. http://dx.doi.org/10.1074/jbc.M703702200.
   PubMedGoogle Scholar
• Chen L, Meng Q, Jing X, Xu P, Luo D. 2011. A role for protein kinase C in the regulation of membrane fluidity and Ca(2)(+) flux at the endoplasmic reticulum and plasma membranes of HEK293 and Jurkat cells. Cell Signal 23:497–505. http://dx.doi.org/10.1016/j.cellsig.2010.11.005.
   PubMedGoogle Scholar
• Prickett TD, Brautigan DL. 2006. The alpha4 regulatory subunit exerts opposing allosteric effects on protein phosphatases PP6 and PP2A. J Biol Chem 281:30503–30511. http://dx.doi.org/10.1074/jbc.M601054200.
   PubMed Web of Science ®Google Scholar
• Muller S, Matunis MJ, Dejean A. 1998. Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J 17:61–70. http://dx.doi.org/10.1093/emboj/17.1.61.
   PubMed Web of Science ®Google Scholar
• Li W, Jiang Z, Li T, Wei X, Zheng Y, Wu D, Yang Y, Chen S, Xu B, Zhong M, Jiang J, Hu Y, Su H, Zhang M, Huang X, Geng S, Weng J, Du X, Liu P, Li Y, Liu H, Yao Y, Li P. 2015. Genome-wide analyses identify KLF4 as an important negative regulator in T-cell acute lymphoblastic leukemia through directly inhibiting T-cell associated genes. Mol Cancer 14:26. http://dx.doi.org/10.1186/s12943-014-0285-x.
   PubMedGoogle Scholar
• Kim YS, Nagy K, Keyser S, Schneekloth SJ, Jr. 2013. An electrophoretic mobility shift assay identifies a mechanistically unique inhibitor of protein sumoylation. Chem Biol 20:604–613. http://dx.doi.org/10.1016/j.chembiol.2013.04.001.
   PubMedGoogle Scholar
• Fukuda I, Ito A, Hirai G, Nishimura S, Kawasaki H, Saitoh H, Kimura K, Sodeoka M, Yoshida M. 2009. Ginkgolic acid inhibits protein SUMOylation by blocking formation of the E1-SUMO intermediate. Chem Biol 16:133–140. http://dx.doi.org/10.1016/j.chembiol.2009.01.009.
   PubMed Web of Science ®Google Scholar
• Hoellein A, Fallahi M, Schoeffmann S, Steidle S, Schaub FX, Rudelius M, Laitinen I, Nilsson L, Goga A, Peschel C, Nilsson JA, Cleveland JL, Keller U. 2014. Myc-induced SUMOylation is a therapeutic vulnerability for B-cell lymphoma. Blood 124:2081–2090. http://dx.doi.org/10.1182/blood-2014-06-584524.
   PubMedGoogle Scholar
• Hemshekhar M, Sebastin Santhosh M, Kemparaju K, Girish KS. 2012. Emerging roles of anacardic acid and its derivatives: a pharmacological overview. Basic Clin Pharmacol Toxicol 110:122–132. http://dx.doi.org/10.1111/j.1742-7843.2011.00833.x.
   PubMed Web of Science ®Google Scholar
• Boulay G, Dubuissez M, Van Rechem C, Forget A, Helin K, Ayrault O, Leprince D. 2012. Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins. J Biol Chem 287:10509–10524. http://dx.doi.org/10.1074/jbc.M111.320234.
   PubMedGoogle Scholar
• Wu CS, Ouyang J, Mori E, Nguyen HD, Marechal A, Hallet A, Chen DJ, Zou L. 2014. SUMOylation of ATRIP potentiates DNA damage signaling by boosting multiple protein interactions in the ATR pathway. Genes Dev 28:1472–1484. http://dx.doi.org/10.1101/gad.238535.114.
   PubMed Web of Science ®Google Scholar
• Van Dessel N, Beke L, Gornemann J, Minnebo N, Beullens M, Tanuma N, Shima H, Van Eynde A, Bollen M. 2010. The phosphatase interactor NIPP1 regulates the occupancy of the histone methyltransferase EZH2 at Polycomb targets. Nucleic Acids Res 38:7500–7512. http://dx.doi.org/10.1093/nar/gkq643.
   PubMedGoogle Scholar
• Boulay G, Rosnoblet C, Guerardel C, Angrand PO, Leprince D. 2011. Functional characterization of human Polycomb-like 3 isoforms identifies them as components of distinct EZH2 protein complexes. Biochem J 434:333–342. http://dx.doi.org/10.1042/BJ20100944.
   PubMedGoogle Scholar
• Dehennaut V, Loison I, Dubuissez M, Nassour J, Abbadie C, Leprince D. 2013. DNA double-strand breaks lead to activation of hypermethylated in cancer 1 (HIC1) by SUMOylation to regulate DNA repair. J Biol Chem 288:10254–10264. http://dx.doi.org/10.1074/jbc.M112.421610.
   PubMedGoogle Scholar
• Dege C, Hagman J. 2014. Mi-2/NuRD chromatin remodeling complexes regulate B and T-lymphocyte development and function. Immunol Rev 261:126–140. http://dx.doi.org/10.1111/imr.12209.
   PubMedGoogle Scholar
• Manavathi B, Singh K, Kumar R. 2007. MTA family of coregulators in nuclear receptor biology and pathology. Nucl Recept Signal 5:e010. http://dx.doi.org/10.1621/nrs.05010.
   PubMedGoogle Scholar
• Satterwhite E, Sonoki T, Willis TG, Harder L, Nowak R, Arriola EL, Liu H, Price HP, Gesk S, Steinemann D, Schlegelberger B, Oscier DG, Siebert R, Tucker PW, Dyer MJ. 2001. The BCL11 gene family: involvement of BCL11A in lymphoid malignancies. Blood 98:3413–3420. http://dx.doi.org/10.1182/blood.V98.12.3413.
   PubMed Web of Science ®Google Scholar
• Durum SK. 2003. Bcl11: sibling rivalry in lymphoid development. Nat Immunol 4:512–514. http://dx.doi.org/10.1038/ni0603-512.
   PubMed Web of Science ®Google Scholar
• Hong W, Nakazawa M, Chen YY, Kori R, Vakoc CR, Rakowski C, Blobel GA. 2005. FOG-1 recruits the NuRD repressor complex to mediate transcriptional repression by GATA-1. EMBO J 24:2367–2378. http://dx.doi.org/10.1038/sj.emboj.7600703.
   PubMed Web of Science ®Google Scholar
• Alqarni SS, Murthy A, Zhang W, Przewloka MR, Silva AP, Watson AA, Lejon S, Pei XY, Smits AH, Kloet SL, Wang H, Shepherd NE, Stokes PH, Blobel GA, Vermeulen M, Glover DM, Mackay JP, Laue ED. 2014. Insight into the architecture of the NuRD complex: structure of the RbAp48-MTA1 subcomplex. J Biol Chem 289:21844–21855. http://dx.doi.org/10.1074/jbc.M114.558940.
   PubMed Web of Science ®Google Scholar
• Kennelly PJ, Krebs EG. 1991. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266:15555–15558.
   PubMed Web of Science ®Google Scholar
• Kong KF, Altman A. 2013. In and out of the bull's eye: protein kinase Cs in the immunological synapse. Trends Immunol 34:234–242. http://dx.doi.org/10.1016/j.it.2013.01.002.
   PubMedGoogle Scholar
• Lejon S, Thong SY, Murthy A, AlQarni S, Murzina NV, Blobel GA, Laue ED, Mackay JP. 2011. Insights into association of the NuRD complex with FOG-1 from the crystal structure of an RbAp48.FOG-1 complex. J Biol Chem 286:1196–1203. http://dx.doi.org/10.1074/jbc.M110.195842.
   PubMed Web of Science ®Google Scholar
• Puente LG, Stone JC, Ostergaard HL. 2000. Evidence for protein kinase C-dependent and -independent activation of mitogen-activated protein kinase in T cells: potential role of additional diacylglycerol binding protein. J Immunol 165:6865–6871. http://dx.doi.org/10.4049/jimmunol.165.12.6865.
   PubMed Web of Science ®Google Scholar
• Huang X, Shen Q, Chen S, Chen S, Yang L, Weng J, Du X, Grabarczyk P, Przybylski GK, Schmidt CA, Li Y. 2011. Gene expression profiles in BCL11B-siRNA treated malignant T cells. J Hematol Oncol 4:23. http://dx.doi.org/10.1186/1756-8722-4-23.
   PubMed Web of Science ®Google Scholar
• Vogel WK, Gafken PR, Leid M, Filtz TM. 2014. Kinetic analysis of BCL11B multisite phosphorylation-dephosphorylation and coupled sumoylation in primary thymocytes by multiple reaction monitoring mass spectroscopy. J Proteome Res 13:5860–5868. http://dx.doi.org/10.1021/pr5007697.
   PubMed Web of Science ®Google Scholar
• Li X, Wang W, Wang J, Malovannaya A, Xi Y, Li W, Guerra R, Hawke DH, Qin J, Chen J. 2015. Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. Mol Syst Biol 11:775. http://dx.doi.org/10.15252/msb.20145504.
   PubMed Web of Science ®Google Scholar
• Ji Z, Sharrocks AD. 2015. Changing partners: transcription factors form different complexes on and off chromatin. Mol Syst Biol 11:782. http://dx.doi.org/10.15252/msb.20145936.
   PubMedGoogle Scholar
• Nair SS, Li DQ, Kumar R. 2013. A core chromatin remodeling factor instructs global chromatin signaling through multivalent reading of nucleosome codes. Mol Cell 49:704–718. http://dx.doi.org/10.1016/j.molcel.2012.12.016.
   PubMedGoogle Scholar
• Lin AC, Roche AE, Wilk J, Svensson EC. 2004. The N termini of Friend of GATA (FOG) proteins define a novel transcriptional repression motif and a superfamily of transcriptional repressors. J Biol Chem 279:55017–55023. http://dx.doi.org/10.1074/jbc.M411240200.
   PubMed Web of Science ®Google Scholar
• Gao Z, Huang Z, Olivey HE, Gurbuxani S, Crispino JD, Svensson EC. 2010. FOG-1-mediated recruitment of NuRD is required for cell lineage re-enforcement during haematopoiesis. EMBO J 29:457–468. http://dx.doi.org/10.1038/emboj.2009.368.
   PubMed Web of Science ®Google Scholar
• Miccio A, Wang Y, Hong W, Gregory GD, Wang H, Yu X, Choi JK, Shelat S, Tong W, Poncz M, Blobel GA. 2010. NuRD mediates activating and repressive functions of GATA-1 and FOG-1 during blood development. EMBO J 29:442–456. http://dx.doi.org/10.1038/emboj.2009.336.
   PubMedGoogle Scholar
• Van Rechem C, Boulay G, Pinte S, Stankovic-Valentin N, Guerardel C, Leprince D. 2010. Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells. Mol Cell Biol 30:4045–4059. http://dx.doi.org/10.1128/MCB.00582-09.
   PubMedGoogle Scholar
• Fujita N, Jaye DL, Geigerman C, Akyildiz A, Mooney MR, Boss JM, Wade PA. 2004. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119:75–86. http://dx.doi.org/10.1016/j.cell.2004.09.014.
   PubMedGoogle Scholar
• Huang C, Gonzalez DG, Cote CM, Jiang Y, Hatzi K, Teater M, Dai K, Hla T, Haberman AM, Melnick A. 2014. The BCL6 RD2 domain governs commitment of activated B cells to form germinal centers. Cell Rep 8:1497–1508. http://dx.doi.org/10.1016/j.celrep.2014.07.059.
   PubMed Web of Science ®Google Scholar
• Parekh S, Polo JM, Shaknovich R, Juszczynski P, Lev P, Ranuncolo SM, Yin Y, Klein U, Cattoretti G, Dalla Favera R, Shipp MA, Melnick A. 2007. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood 110:2067–2074. http://dx.doi.org/10.1182/blood-2007-01-069575.
   PubMed Web of Science ®Google Scholar
• Nance JP, Belanger S, Johnston RJ, Hu JK, Takemori T, Crotty S. 2015. Bcl6 middle domain repressor function is required for T follicular helper cell differentiation and utilizes the corepressor MTA3. Proc Natl Acad Sci U S A 112:13324–13329. http://dx.doi.org/10.1073/pnas.1507312112.
   PubMedGoogle Scholar
• Huang X, Chen S, Shen Q, Chen S, Yang L, Grabarczyk P, Przybylski GK, Schmidt CA, Li Y. 2011. Down regulation of BCL11B expression inhibits proliferation and induces apoptosis in malignant T cells by BCL11B-935-siRNA. Hematology 16:236–242. http://dx.doi.org/10.1179/102453311X13025568941961.
   PubMed Web of Science ®Google Scholar
• Conomos D, Reddel RR, Pickett HA. 2014. NuRD-ZNF827 recruitment to telomeres creates a molecular scaffold for homologous recombination. Nat Struct Mol Biol 21:760–770. http://dx.doi.org/10.1038/nsmb.2877.
   PubMed Web of Science ®Google Scholar
• Cismasiu VB, Paskaleva E, Suman Daya S, Canki M, Duus K, Avram D. 2008. BCL11B is a general transcriptional repressor of the HIV-1 long terminal repeat in T lymphocytes through recruitment of the NuRD complex. Virology 380:173–181. http://dx.doi.org/10.1016/j.virol.2008.07.035.
   PubMed Web of Science ®Google Scholar